|
Alleviant ALLAY-HFrEF Study
RECRUITINGN/ASponsored by Alleviant Medical, Inc.
Actively Recruiting
PhaseN/A
SponsorAlleviant Medical, Inc.
Started2025-03-10
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations40 sites
View on ClinicalTrials.gov →
NCT06812533
Summary
Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * LVEF ≤ 40% * NYHA class II, III or ambulatory IV HF * Receiving optimal, maximally tolerated, stable GDMT Exclusion Criteria: * Advanced heart failure * Life-expectancy \< 12 months * Evidence of right heart dysfunction
Conditions2
Heart DiseaseHeart Failure
Locations40 sites
Find trials near these locations
Heart Disease trials in Los AngelesHeart Disease trials in SacramentoHeart Disease trials in San DiegoHeart Disease trials in San FranciscoHeart Disease trials in TampaHeart Disease trials in New OrleansHeart Disease trials in BostonHeart Disease trials in MinneapolisHeart Disease trials in Las VegasHeart Disease trials in New YorkHeart Disease trials in RaleighHeart Disease trials in ClevelandAll trials in CaliforniaAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in LouisianaAll trials in MassachusettsAll trials in MinnesotaAll trials in MissouriAll trials in NevadaAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in PennsylvaniaAll trials in TennesseeAll trials in TexasAll trials in Virginia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorAlleviant Medical, Inc.
Started2025-03-10
Est. completion2028-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations40 sites
View on ClinicalTrials.gov →
NCT06812533